Literature DB >> 36114947

The Genetics of Eczema Herpeticum.

Elisabeth Hodara1, Peck Y Ong2,3.   

Abstract

Eczema herpeticum (EH) is a viral skin infection caused by herpes simplex virus (HSV) superimposed on eczematous skin lesions in atopic dermatitis (AD). Though the pathogenesis of EH has yet to be fully elucidated, the fact that EH is relatively rare despite a majority of adults showing serologic evidence of HSV exposure points to a genetic component predisposing to the disease. A number of genetic variants have been isolated in EH which may help distinguish a subgroup of patients susceptible to developing the condition. These unique genetic characteristics include deficiencies in skin barrier function and hydration, as well as at the level of the immune system. In this review, we summarize the genetic findings associated with EH identified to date. Isolating genetic markers in EH will be instrumental in stratifying patients at risk for EH and will have significant implications in the development and tailoring of targeted therapies.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Atopic dermatitis; Herpes simplex virus; Infectious complications; Viral infection

Year:  2022        PMID: 36114947     DOI: 10.1007/s12016-022-08953-x

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   10.817


  72 in total

Review 1.  Tight junctions/adherens junctions: basic structure and function.

Authors:  Carien M Niessen
Journal:  J Invest Dermatol       Date:  2007-11       Impact factor: 8.551

2.  Atopic dermatitis.

Authors:  Thomas Bieber
Journal:  N Engl J Med       Date:  2008-04-03       Impact factor: 91.245

Review 3.  Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis.

Authors:  Jacob P Thyssen; Sanja Kezic
Journal:  J Allergy Clin Immunol       Date:  2014-07-25       Impact factor: 10.793

4.  Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis.

Authors:  Anna De Benedetto; Mark K Slifka; Nicholas M Rafaels; I-Hsin Kuo; Steve N Georas; Mark Boguniewicz; Tissa Hata; Lynda C Schneider; Jon M Hanifin; Richard L Gallo; David C Johnson; Kathleen C Barnes; Donald Y M Leung; Lisa A Beck
Journal:  J Allergy Clin Immunol       Date:  2011-04-13       Impact factor: 10.793

5.  Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go?

Authors:  Thomas Bieber; Angelo M D'Erme; Cezmi A Akdis; Claudia Traidl-Hoffmann; Roger Lauener; Georg Schäppi; Peter Schmid-Grendelmeier
Journal:  J Allergy Clin Immunol       Date:  2017-04       Impact factor: 10.793

6.  Why is eczema herpeticum unexpectedly rare?

Authors:  Donald Y M Leung
Journal:  Antiviral Res       Date:  2013-02-22       Impact factor: 5.970

7.  Disruption of adherens junctions liberates nectin-1 to serve as receptor for herpes simplex virus and pseudorabies virus entry.

Authors:  Miri Yoon; Patricia G Spear
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury.

Authors:  Jürgen Harder; Stefanie Dressel; Maike Wittersheim; Jesko Cordes; Ulf Meyer-Hoffert; Ulrich Mrowietz; Regina Fölster-Holst; Ehrhard Proksch; Jens-Michael Schröder; Thomas Schwarz; Regine Gläser
Journal:  J Invest Dermatol       Date:  2010-01-28       Impact factor: 8.551

9.  IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication.

Authors:  Byung Eui Kim; Lianghua Bin; Young-Min Ye; Preveen Ramamoorthy; Donald Y M Leung
Journal:  J Invest Dermatol       Date:  2013-05-08       Impact factor: 8.551

Review 10.  The infectious complications of atopic dermatitis.

Authors:  Vivian Wang; Juri Boguniewicz; Mark Boguniewicz; Peck Y Ong
Journal:  Ann Allergy Asthma Immunol       Date:  2020-08-07       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.